Treatment Planning System Commissioning of the Eclipse PBC Dose Calculation Algorithm for the Varian Clinac iX S/N 5052
Date Issued
2013-10-19
Author(s)
Nikolovski, Dragan
Abstract
The commissioning of the Treatment Planning System (TPS) is an important part of the
commissioning of a new linear accelerator (linac). In this work, we evaluated the performance of the Pencil Beam Convolution (PBC) algorithm configured for the new Varian Clinac iX (S/N 5052) at the University Clinic of Radiotherapy and Oncology in Skopje. The evaluation was performed in two stages.
In the first stage, we used a workspace of the TPS itself, called “Beam Analysis”, in which the system itself calculates the depth dose and profile curves for a water phantom and compares them with those measured during the commissioning of the accelerator. In the second stage, we created, calculated and irradiated 9 test plans on a polystyrene phantom “OPERA” and measured the dose in a point with a system for absolute dosimetry and then compared the measurements with the calculations. In both stages, the results of the comparison were below 3%, in most clinically relevant cases below 2%, which indicates that the PBC algorithm can safely be commissioned for clinical use.
commissioning of a new linear accelerator (linac). In this work, we evaluated the performance of the Pencil Beam Convolution (PBC) algorithm configured for the new Varian Clinac iX (S/N 5052) at the University Clinic of Radiotherapy and Oncology in Skopje. The evaluation was performed in two stages.
In the first stage, we used a workspace of the TPS itself, called “Beam Analysis”, in which the system itself calculates the depth dose and profile curves for a water phantom and compares them with those measured during the commissioning of the accelerator. In the second stage, we created, calculated and irradiated 9 test plans on a polystyrene phantom “OPERA” and measured the dose in a point with a system for absolute dosimetry and then compared the measurements with the calculations. In both stages, the results of the comparison were below 3%, in most clinically relevant cases below 2%, which indicates that the PBC algorithm can safely be commissioned for clinical use.
File(s)![Thumbnail Image]()
Loading...
Name
Lukarski_ThirdConference pg.33.pdf
Size
329.49 KB
Format
Adobe PDF
Checksum
(MD5):f25f94efffeacc2fb0b1df1332bf61aa